acute rejection kidney transplantation renal biopsy immunosuppression As the interest in telehealth and remote monitoring increases,1 many transplant practitioners have turned to donor-derived cell-free DNA (dd-cfDNA) to noninvasively monitor the immunologic status of allografts. As use of this testing grows, it is important to highlight limitations in its predictive value. There are several available dd-cfDNA tests.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile